{"cluster": 20, "subcluster": 42, "abstract_summ": "SELECTION CRITERIA We included test accuracy studies of any design that evaluated antibody tests (including enzyme-linked immunosorbent assays, chemiluminescence immunoassays, and lateral flow assays) in people suspected of current or previous SARS-CoV-2 infection, or where tests were used to screen for infection.Results IgG antibody responses to one S antigen identified individuals with previous RT-qPCR confirmed SARS-CoV-2 infection with 90.3% sensitivity (95% confidence interval (CI); 86.1%, 93.4%) and 99.1% specificity (95% CI; 97.4%, 99.7%).Serology tests to detect the presence of antibodies to SARS-CoV-2 aim to identify previous SARS-CoV-2 infection, and may help to confirm the presence of current infection.A mathematical model of antibody kinetics informed by prior information from other coronaviruses was used to estimate time-varying antibody responses and assess the potential sensitivity and classification performance of serological diagnostics during the first year following symptom onset.Importantly, these assays do not require handling of infectious virus, can be adjusted to detect different antibody types and are amendable to scaling.", "title_summ": "SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigationSARS-CoV-2 specific antibody responses in COVID-19 patientsSerological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnosticsAnalysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen MicroarrayA serological assay to detect SARS-CoV-2 seroconversion in humansDetection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assaySevere Acute Respiratory Syndrome Coronavirus 2\u2212Specific Antibody Responses in Coronavirus Disease PatientsAntibody tests for identification of current and past infection with SARS-CoV-2.SARS\u2010CoV\u20102 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupSerological differentiation between COVID-19 and SARS infections.", "title_abstract_phrases": "Serology tests to detect the presence of antibodies to SARS-CoV-2 aim to identify previous SARS-CoV-2 infection, and may help to confirm the presence of current infection.We discovered that anti-N antibodies waned more than anti-RBD antibodies, and the latter is known to play a more important role in providing protective immunity.SELECTION CRITERIA We included test accuracy studies of any design that evaluated antibody tests (including enzyme-linked immunosorbent assays, chemiluminescence immunoassays, and lateral flow assays) in people suspected of current or previous SARS-CoV-2 infection, or where tests were used to screen for infection.Results IgG antibody responses to one S antigen identified individuals with previous RT-qPCR confirmed SARS-CoV-2 infection with 90.3% sensitivity (95% confidence interval (CI); 86.1%, 93.4%) and 99.1% specificity (95% CI; 97.4%, 99.7%).This array can be used as a diagnostic tool, as an epidemiologic tool to more accurately estimate the disease burden of COVID-19, and as a research tool to correlate antibody responses with clinical outcomes."}